Galmed Pharmaceuticals Ltd. EOCN
3.63
0.01
0.28%
as of 25 Sep
- Market cap
- $3.8M
- P/E
- 0.0×
Follow EOCN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (68.21%) | (72.12%) | (64.21%) | (46.34%) |
+8 more TTM periods Free account |
|
| (55.03%) | (64.04%) | (55.53%) | (40.91%) | ||
ROIC |
(163.19%) | (94.52%) | (114.43%) | (59.29%) | |
Return on Tangible Assets |
(126.78%) | (79.69%) | (65.32%) | (50.43%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(8.97) | (9.33) | (11.72) | (9.20) | |
Free Cash Flow |
(8.54) | (7.68) | (6.31) | (6.28) | |
| Other line items | |||||
Cash ROIC |
(39.44%) | (35.32%) | (23.46%) | (20.43%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.75 | 0.69 | 0.61 | 0.72 | |
Depreciation/Fixed assets |
(0.06) | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(8.97) | (9.33) | (11.72) | (9.20) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates